Kevin Muir is GM INTERVENTIONAL ONCOLOGY of DELCATH SYSTEMS, INC.. Currently has a direct ownership of 18,582 shares of DCTH, which is worth approximately $181,360. The most recent transaction as insider was on Mar 19, 2024, when has been sold 13,441 shares (Common Stock) at a price of $3.72 per share, resulting in proceeds of $50,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.6K
0% 3M change
n/a 12M change
Total Value Held $181,360

Kevin Muir Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2024
BUY
Grant, award, or other acquisition
$50,000 $3.72 p/Share
13,441 Added 41.97%
18,582 Common Stock
KM

Kevin Muir

GM INTERVENTIONAL ONCOLOGY
New York, NY

Track Institutional and Insider Activities on DCTH

Follow DELCATH SYSTEMS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCTH shares.

Notify only if

Insider Trading

Get notified when an Delcath Systems, Inc. insider buys or sells DCTH shares.

Notify only if

News

Receive news related to DELCATH SYSTEMS, INC.

Track Activities on DCTH